Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-20T04:33:44.409Z Has data issue: false hasContentIssue false

3 - Nuclear cloning, embryonic stem cells, and gene transfer

Published online by Cambridge University Press:  29 January 2010

John Rasko
Affiliation:
University of Sydney
Gabrielle O'Sullivan
Affiliation:
University of Sydney
Rachel Ankeny
Affiliation:
University of Sydney
Get access

Summary

An emerging consensus is that somatic cell nuclear transfer (SCNT) for the purpose of creating a child (also called “reproductive cloning”) is not acceptable for both moral and scientific reasons. In contrast, SCNT with the goal of generating an embryonic stem (ES) cell line (so-called “therapeutic cloning”) remains a controversial issue. Although therapeutic cloning holds the promise of yielding new ways of treating a number of degenerative diseases, it is not acceptable to many because the derivation of an ES cell line from the cloned embryo (an essential step in this process) necessarily involves the loss of an embryo and hence the destruction of potential human life.

In this chapter, I develop two main arguments that are based on the available scientific evidence. First, in contrast to an embryo derived by in vitro fertilization (IVF), a cloned embryo has little, if any, potential to ever develop into a normal human being. By circumventing the normal processes of gametogenesis and fertilization, nuclear cloning prevents the proper reprogramming of the clone's genome, which is a prerequisite for development of an embryo to a normal individual. It is unlikely that these biologic barriers to normal development can be solved in the foreseeable future. Therefore, from a biologist's point of view, the cloned human embryo which is to be used for the derivation of an ES cell and the subsequent transfer into a patient in need has little if any potential to create a normal human life.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×